ECTMIH 2017

October 16-20, 2017
Antwerp, Belgium
DNDi presented on sleeping sickness, visceral leishmaniasis, mycetoma, and onchocerciasis.

World Health Summit 2017

October 15-17, 2017
Berlin, Germany
Monique Wasunna, Director of DNDi Africa, presented on strengthening capacity for visceral leishmaniasis clinical research in Africa.

Celgene joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases

[Summit, New Jersey and Geneva, Switzerland – June 15, 2016]
First US-based biopharmaceutical partner to join global consortium
The biopharmaceutical company Celgene has become the fifth company to join the “Neglected Tropical Diseases Drug Discovery Booster” consortium, a new initiative to accelerate and cut the cost of early stage drug discovery for two of the world’s most neglected diseases, leishmaniasis and Chagas disease.